• Home
  • NEW DAY MEDICINE
  • 9 (83) 2025
  • 32 -9 (83) 2025 - Nurbayev F., Omonov O. - COMPARATIVE DESCRIPTION OF MEDICAL RISK FACTORS AFFECTING THE CLINICAL COURSE OF COVID-19 DISEASE

32 -9 (83) 2025 - Nurbayev F., Omonov O. - COMPARATIVE DESCRIPTION OF MEDICAL RISK FACTORS AFFECTING THE CLINICAL COURSE OF COVID-19 DISEASE

COMPARATIVE DESCRIPTION OF MEDICAL RISK FACTORS AFFECTING THE CLINICAL COURSE OF COVID-19 DISEASE

Nurbayev F. - Bukhara State Medical Institute named after Abu Ali ibn Sina

Omonov O. - Bukhara State Medical Institute named after Abu Ali ibn Sina

Resume

This article presents an analysis of data formed based on a retrospective study of the medical histories of 2002 patients hospitalized with COVID-19 in the Bukhara Regional Multidisciplinary Hospital and the Regional Infectious Diseases Hospital during 2020 and 2022. It presents a classification of medical risk factors that may affect the course of COVID-19.

Keywords: COVID-19, medical risk factors, age factor, patient gender, comorbidities.

First page

201

Last page

205

For citation:Nurbayev F., Omonov O. - COMPARATIVE DESCRIPTION OF MEDICAL RISK FACTORS AFFECTING THE CLINICAL COURSE OF COVID-19 DISEASE//New Day in Medicine 9(83)2025 201-205 https://newdayworldmedicine.com/en/new_day_medicine/9-83-2025

List of References

  1. Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395:565–74. https://doi.org/10.1016/S0140-6736(20)30251 -8.
  2. World Health Organization. WHO best practices for naming of new human infectious diseases. 2015. https://www.who.int/topic s/infectious_diseases/naming-new-diseases/en/. Accessed 14 Apr 2020.
  3. World Health Organization. Disease outbreak news. 2020. https ://www.who.int/csr/don/05-january-2020-pneumonia-of-unkow n-cause-china/en/. Accessed 15 Apr 2020.
  4. TA Ghebreyesus. WHO Director-General’s opening remarks at the media briefing on COVID-19—11 March 2020; 2020.
  5. Chan JF-W, Yuan S, Kok K-H, To KK-W, Chu H, Yang J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020;395:514–23. https://doi.org/10.1016/ S0140-6736(20)30154-9.
  6. John Hopkins University. COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU). 2020. https://coronavirus.jhu.edu/map.html. Accessed 14 Apr 2020.
  7. Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. 2020. https ://doi.org/10.1016/S1473-3099(20)30120-1.
  8. Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DKW, et al. Detection of 2019 novel coronavirus (2019- nCoV) by real-time RT-PCR. Euro Surveill. 2020. https://doi. org/10.2807/1560-7917.ES.2020.25.3.2000045.
  9. Li X, Geng M, Peng Y, Meng L, Lu S. Molecular immune pathogenesis and diagnosis of COVID-19. J Pharm Anal. 2020. https://doi.org/10.1016/j.jpha.2020.03.001.
  10. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506. https://doi. org/10.1016/S0140-6736(20)30183-5.
  11. Rajgor DD, Lee MH, Archuleta S, Bagdasarian N, Quek SC. The many estimates of the COVID-19 case fatality rate. Lancet Infect Dis. 2020. https://doi.org/10.1016/S1473-3099(20)30244 -9.
  12. Lai C-C, Liu YH, Wang C-Y, et al. Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARSCoV-2): Facts and myths. J Microbiol Immunol Infect. 2020; 53 (3), 404-12.
  13. Wang P, Lu J, Jin Y, Zhu M, Wang L, Chen S. Statistical and network analysis of 1212 COVID-19 patients in Henan, China. Int J Infect Dis. 2020; 95, 391-8.
  14. Guan W-j, Ni Z-y, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708-20.
  15. Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507-13.
  16. Chan JF-W, Yuan S, Kok K-H, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. The Lancet. 2020;395(10223):514-23.
  17. Opal SM, Girard TD, Ely EW. The immunopathogenesis of sepsis in elderly patients. Clin Infect Dis. 2005;41(Suppl. 7):504-12.
  18. Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507-13.
  19. Ozma MA, Rashedi J, Poor BM, et al. Tuberculosis and diabetes mellitus in Northwest of Iran. Infect Disord Drug Targets. 2019. doi: 10.2174/187152651966 6190715142100
  20. Gallagher PE, Ferrario CM, Tallant EA. Regulation of ACE2 in cardiac myocytes and fibroblasts. Am J Physiol Heart Circ Physiol. 2008;295(6):2373-9.

    file

    download